FI954876A - Hajapesäkkeiseen skleroosiin liittyvä sytoksinen tekijä, sen havaitseminen ja kvantitointi - Google Patents

Hajapesäkkeiseen skleroosiin liittyvä sytoksinen tekijä, sen havaitseminen ja kvantitointi Download PDF

Info

Publication number
FI954876A
FI954876A FI954876A FI954876A FI954876A FI 954876 A FI954876 A FI 954876A FI 954876 A FI954876 A FI 954876A FI 954876 A FI954876 A FI 954876A FI 954876 A FI954876 A FI 954876A
Authority
FI
Finland
Prior art keywords
quantification
detection
multiple sclerosis
factor associated
cytotoxic factor
Prior art date
Application number
FI954876A
Other languages
English (en)
Swedish (sv)
Other versions
FI954876A0 (fi
Inventor
Herve Perron
Thomas Dobransky
Francois Rieger
Bernard Mandrand
Original Assignee
Bio Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux filed Critical Bio Merieux
Publication of FI954876A publication Critical patent/FI954876A/fi
Publication of FI954876A0 publication Critical patent/FI954876A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/16—Dendrimers and dendritic polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/964—Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/828—Protein A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI954876A 1994-02-15 1995-10-13 Hajapesäkkeiseen skleroosiin liittyvä sytoksinen tekijä, sen havaitseminen ja kvantitointi FI954876A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9401946A FR2716198B1 (fr) 1994-02-15 1994-02-15 Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
PCT/FR1995/000178 WO1995021859A1 (fr) 1994-02-15 1995-02-15 Facteur cytotoxique tel qu'associe a la sclerose en plaques, sa detection et sa quantification

Publications (2)

Publication Number Publication Date
FI954876A true FI954876A (fi) 1995-10-13
FI954876A0 FI954876A0 (fi) 1995-10-13

Family

ID=9460272

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954876A FI954876A0 (fi) 1994-02-15 1995-10-13 Hajapesäkkeiseen skleroosiin liittyvä sytoksinen tekijä, sen havaitseminen ja kvantitointi

Country Status (13)

Country Link
US (2) US5876954A (fi)
EP (1) EP0667354B1 (fi)
JP (1) JP2803910B2 (fi)
AT (1) ATE205856T1 (fi)
AU (1) AU701972B2 (fi)
CA (1) CA2142557C (fi)
DE (1) DE69522725T2 (fi)
DK (1) DK0667354T3 (fi)
FI (1) FI954876A0 (fi)
FR (1) FR2716198B1 (fi)
NO (1) NO954081L (fi)
NZ (1) NZ281260A (fi)
WO (1) WO1995021859A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU704440B2 (en) 1994-02-04 1999-04-22 Bio Merieux MSRV1 virus and MSRV2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
US6284236B1 (en) * 1995-06-29 2001-09-04 Immunex Corporation Cytokine that induces apoptosis
FR2745974B1 (fr) * 1996-03-14 1998-04-17 Animal modifie, utilisations et procede pour mesurer l'efficacite d'un procede therapeutique
DK0925504T3 (da) 1996-09-12 2001-07-23 Bio Merieux Fremgangsmåde til påvisning og/eller kvantitativ bestemmelse af en gliotoksisk faktor
EP0942987B1 (en) 1996-11-26 2009-08-19 Bio Merieux Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
FR2765588A1 (fr) 1997-07-07 1999-01-08 Bio Merieux Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques
FR2797402B1 (fr) * 1999-07-15 2004-03-12 Biomerieux Stelhys Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346074A (en) * 1978-08-24 1982-08-24 National Research Development Corp. Pasteurellosis vaccines
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
US4396600A (en) * 1980-12-18 1983-08-02 Gus Gallucci Adult schistosome worm-derived antigenic substance and method of obtaining same
US4388298A (en) * 1982-07-14 1983-06-14 The United States Of America As Represented By The Secretary Of Agriculture Propagation of hemorrhagic enteritis virus in a turkey cell line and vaccine produced
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
US4647773A (en) * 1984-04-23 1987-03-03 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
US4900553A (en) * 1987-09-11 1990-02-13 Case Western Reserve University Method of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
EP0326395A2 (en) * 1988-01-29 1989-08-02 City Of Hope Method of detecting and identifying certain viral sequences
FR2651581B1 (fr) * 1989-09-06 1994-05-13 Centre Nal Recherc Scientifique Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques.
US5219837A (en) * 1990-06-21 1993-06-15 Trustees Of The University Of Pennsylvania Method of stimulating myelination of cells
US5158976A (en) * 1990-10-29 1992-10-27 The Children's Medical Center Corporation Controlling glutamine/glutamate related neuronal injury
DK173091D0 (da) * 1991-10-11 1991-10-11 Schleroseforeningen The Danish Biologisk materiale
FR2689520B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
FR2689521B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
CA2117893A1 (en) * 1992-05-18 1993-11-25 Paul J. Godowski Variant dimers for receptor activation
GB9310657D0 (en) * 1993-05-24 1993-07-07 Univ London Retrovirus

Also Published As

Publication number Publication date
CA2142557C (fr) 2001-11-20
ATE205856T1 (de) 2001-10-15
CA2142557A1 (fr) 1995-08-16
EP0667354A1 (fr) 1995-08-16
WO1995021859A1 (fr) 1995-08-17
FR2716198B1 (fr) 1996-04-19
NO954081D0 (no) 1995-10-13
EP0667354B1 (fr) 2001-09-19
NO954081L (no) 1995-12-13
NZ281260A (en) 1998-05-27
JP2803910B2 (ja) 1998-09-24
DK0667354T3 (da) 2002-01-14
JPH08511808A (ja) 1996-12-10
US5876954A (en) 1999-03-02
DE69522725D1 (de) 2001-10-25
FI954876A0 (fi) 1995-10-13
AU701972B2 (en) 1999-02-11
AU1815295A (en) 1995-08-29
DE69522725T2 (de) 2002-07-04
FR2716198A1 (fr) 1995-08-18
US5728540A (en) 1998-03-17

Similar Documents

Publication Publication Date Title
ITMI940326A0 (it) Derivati del 3,8-diazabiciclo[3.2.1.]lottano ad attivita' analgesica
IT1229195B (it) Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
FI943718A (fi) Piperatsiini- ja piperadiinijohdannaisia ja niiden käyttö antipsykoottisina aineina
ATE265997T1 (de) Substituierte tetrahydronaphthalin- und dihydronaphthalin-derivate mit einer retinoiden und/oder retinoid antagonist-ähnlichen biologischen aktivität
ITMI931518A0 (it) Derivati eparinici ad attivita' antimetastatica
FI930070A (fi) Hiv-inhiberande benzenacetamidderivat
FI932074A (fi) Anordning foer att i en bearbetningsanlaeggning transportera och positionera foerdelaktigt laongstraeckta arbetsstycken, saerskilt arbetsstycken av trae
IT9019754A0 (it) Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
FI954876A (fi) Hajapesäkkeiseen skleroosiin liittyvä sytoksinen tekijä, sen havaitseminen ja kvantitointi
DE68900210D1 (de) Pyranobenzoxadiazolderivate, herstellung, verwendung und diese enthaltende zubereitungen.
LV10870A (lv) Jauni fosfolipidu atvasinajumi
FR2682457B1 (fr) Feu d'avertissement tournant, du type gyrophare.
FI934468A0 (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter
FR2671794B1 (fr) Verre d'ophtalmologie tres resistant aux acides.
DE69016196D1 (de) Propanolderivate und diese enthaltende Duftstoffe.
ITMI912422A1 (it) Derivati ossimici ad attivita' fungicida
FI950303A (fi) Pyridoindolobentsodiatsepiinit ja johdannaiset antipsykoottisina aineina
FI945561A (fi) Triatyyliboraanijohdannaisia, niiden valmistus ja niiden käyttö synteesivälituotteina
FI932595A (fi) En vattenhaltig, polymerisk, viskositet upphoejande komposition
ATE126981T1 (de) Aufhängungshalterung und diese enthaltende aufhängungsanordnung.
ITMI922071A0 (it) Derivati xantonici, loro preparazione ed attivita'
FR2702768B1 (fr) Nouveaux mono-amides de la Carpaïne, leur préparation et leur application en tant que médicaments.
FI943489A (fi) 2,2-dialkyyli- ja 2,2-dialkyyli-3,4-dihydro-3-hydroksi-2H-1-bentsopyraaneja
BR9200439A (pt) Insinerador de fumacas acidas,gazes toxicos e outras
IT9020392A1 (it) Derivati 4-piridonici ad attivita' antibatterica e procedimento per la loro preparazione